Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

10 Citations (Scopus)

Abstract

Lymphocyte potassium and magnesium were measured before and 3 months after the introduction of captopril in 18 patients taking diuretics for congestive heart failure. Compared to 32 healthy controls, 9 patients who had been on potassium supplements plus frusemide had decreased baseline lymphocyte magnesium and potassium concentrations (p less than 0.01), in spite of similar plasma electrolyte levels. There was a significant (p less than 0.01) increase in both lymphocyte potassium and magnesium levels after 3 months treatment with captopril and frusemide in these patients. Nine patients who had been taking a potassium-sparing combination diuretic also had an increase in lymphocyte magnesium (p less than 0.05) following the introduction of captopril. Increased intracellular potassium and magnesium may be one mechanism whereby angiotensin-converting enzyme inhibitors reduced arrhythmias and improve survival in patients with congestive heart failure.
Original languageEnglish (Ireland)
Pages (from-to)100-105
Number of pages6
JournalCardiology
Volume80
Issue number2
Publication statusPublished - 1 Jan 1992

Keywords

  • Angiotensin-converting enzyme inhibitors
  • Captopril
  • Congestive heart failure
  • Diuretics
  • Lymphocyte magnesium
  • Lymphocyte potassium

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • O'Keeffe S, Grimes H, Finn J, McMurrough P, Daly K

Fingerprint

Dive into the research topics of 'Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.'. Together they form a unique fingerprint.

Cite this